Physician profile
Michael A Gould
NPI 1902825847
$2,763,933.61
in general payments reported to CMS, 2019-2025
5 companies · $643K in 2025
The $643K reported for 2025 was more than what 99% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $99.72 · 2021: $579K · 2022: $487K · 2023: $499K · 2024: $556K · 2025: $643K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1.7M · Travel and Lodging: $5,249 · Food and Beverage: $58.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,692,257.93 |
| Travel and Lodging | $5,249.23 |
| Food and Beverage | $58.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,483,498.54 | 2019-2023 | |
| Abbvie INC. | $1,242,859.57 | 2023-2025 | |
| Medtronic, INC. | $37,440.00 | 2025 | Graftonand Grafton Plusdemineralized Bone Matrix (Dbm) |
| Astrazeneca Pharmaceuticals Lp | $121.09 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gould listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.